Metastatic Pancreatic Adenocarcinoma

An adenocarcinoma that arises from the exocrine pancreatic tissue and has metastasized to other anatomic sites.

Topic mentions per year

Topic mentions per year

2001-2018
051020012018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Intravenous liposomal irinotecan injection (Onivyde®) is approved for use in combination with 5-fluorouracil and leucovorin (5-FU… (More)
Is this relevant?
2016
2016
Pelareorep causes oncolysis in tumor cells with activated Ras. We hypothesized that pelareorep would have efficacy and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2016
2016
OBJECTIVES Development of targeted therapies for pancreatic cancer could be enhanced by a reliable method for noninvasive tumor… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2016
Review
2016
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and clinically challenging malignancies to treat, with an… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2016
2016
Total pancreatectomy with islet autotransplantation (TPIAT) is being used increasingly as a definitive treatment for chronic… (More)
Is this relevant?
2016
2016
PURPOSE This study focused on implementation of a prognostic scoring index based on clinico-laboratory parameters measured… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Since the US Food and Drug Administration's approval of gemcitabine in 1996, numerous randomized trials have investigated… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
PURPOSE In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause… (More)
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
Review
2014
Review
2014
Gemcitabine monotherapy has been the standard of care for patients with metastatic pancreatic cancer for several decades. Despite… (More)
  • table 2
Is this relevant?
Review
2001
Review
2001
Pancreatic adenocarcinoma is a deadly disease. Its etiology is unknown, and metastatic disease kills themajority of patients who… (More)
Is this relevant?